Loading clinical trials...

COMPLETEDNA

Family Integrated Care: A Feasibility Study in a Level II Special Care Nursery

From Intention to Implementation: Evaluating the Feasibility and Acceptability of Family Integrated Care in Special Care Nursery

NCT07122830•KK Women's and Children's Hospital

View on ClinicalTrials.gov

Summary

The goal of this mixed methods study is to assess the feasibility and acceptability of a parent-led family integrated care program in a Level II neonatal unit. The main questions it aims to answer are: * Is it feasible to implement a parent-led Family Integrated Care (FIC) program in a Level II neonatal unit? * How acceptable is the FIC program to parents and nurses? * Can the FIC program help improve parental self-efficacy and infant outcomes?

Eligibility

Age

21 - No limit years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Parents of infants admitted to the Level II neonatal unit who anticipate at least 2 weeks of stay
•Parents of infants who can commit to coming daily for one to two hours.

Exclusion Criteria

•Infants have severe congenital anomalies
•Infants receiving pallitaive care
•Infants who are critically ill / deemed unlikely to survive
•Infants scheduled for early transfer
•Parents are unable to participate due to health, social, or language issues that would inhibit their communication with the medical and nursing team.

Locations (1)

KK Women's and Children's Hospital

Singapore, Singapore

Key Dates

Start Date

May 15, 2024

Primary Completion Date

April 24, 2025

Completion Date

April 24, 2025

Last Updated

August 14, 2025

Enrollment

ACTUAL participants

Conditions

Family Centered CareNeonatal

Interventions

Family Education and Parental Involvement

OTHER

Efficacy & Safety of Oral Adjuvants to Phototherapy in Neonatal Hyperbilirubinemia

NCT06517862

Neonatal Hyperbilirubinemia

View study

RECRUITINGPHASE3

A Study of Nipocalimab or Intravenous Immunoglobulin (IVIG) in Pregnancies At Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)

NCT06533098

Thrombocytopenia, Neonatal Alloimmune

View study

RECRUITING

Critical Care Optimized Pediatric and Neonatal Quantitative Neuromonitoring

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 14, 2025Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Family Integrated Care: A Feasibility Study in a Level II Special Care Nursery

Inclusion Criteria

Exclusion Criteria

Efficacy & Safety of Oral Adjuvants to Phototherapy in Neonatal Hyperbilirubinemia

A Study of Nipocalimab or Intravenous Immunoglobulin (IVIG) in Pregnancies At Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)

Critical Care Optimized Pediatric and Neonatal Quantitative Neuromonitoring

Italian Validation of a Pressure Injury Risk Assessment Scale (Braden QDS) in the Neonatal Intensive Care Unit

Chlorhexidine Gluconate and Alcohol Hand Rubbing on Healthcare-associated Infection

Virtual Reality-Enhanced Parent Education in Neonatal Intensive Care